TheraRadar
Data updated: May 26, 2026

VARIBAR PUDDING (barium sulfate)

X-Ray Contrast Activity
Other Approved 2016-10-14

Varibar Pudding is a contrast agent used during modified barium swallow examinations to assess how the mouth and throat function. It helps patients ranging from six-month-old infants to adults by allowing healthcare providers to visualize the structure and movement of the oral and pharyngeal regions. This specialized preparation is used to identify issues with swallowing mechanics and physical abnormalities in the upper digestive tract.

Source: FDA Label • BRACCO • Radiographic Contrast Agent

How VARIBAR PUDDING Works

This agent works by utilizing barium, an element with a high atomic number that is opaque to x-rays. When used during imaging, it acts as a positive contrast agent to make internal structures visible. This allows for a clear radiographic view of the areas being studied during a swallow test.

1
Indication
--
Phase 3 Trials
9
Years on Market

Details

Status
Prescription
First Approved
2016-10-14
Routes
ORAL
Dosage Forms
PASTE

Companies

Active Ingredient: BARIUM SULFATE

VARIBAR PUDDING Approval History

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
1 FDA actions from 2016 to 2016
Oct 2016 ORIGINAL
Update · Type 7 - Drug Already Marketed without Approved NDA

What VARIBAR PUDDING Treats

2 indications

VARIBAR PUDDING is approved for 2 conditions since its original approval in 2016. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Oral and pharyngeal function impairment
  • Oral and pharyngeal morphological abnormalities
Source: FDA Label
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

VARIBAR PUDDING FDA Label Details

Indications & Usage

FDA Label (PDF)

VARIBAR PUDDING is indicated for the treatment of Oral and pharyngeal function impairment; Oral and pharyngeal morphological abnormalities.

Track VARIBAR PUDDING with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.